Showing results (231-240 of 294) with videos related to
Sort By:
Pageof 30
Journal of Clinical Pharmacology|May 1, 1997
Influence of oral contraceptive use and cigarette smoking, alone and together, on antipyrine pharmacokineticsJ M Scavone, D J Greenblatt, D R Abernethy, et al.Journal of Clinical Psychopharmacology|June 1, 2000
Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolamG B Kaplan, D J Greenblatt, B L Ehrenberg, et al.Biochemical Pharmacology|February 4, 1998
In vitro approaches to predicting drug interactions in vivoL L von Moltke, D J Greenblatt, J Schmider, et al.Journal of Clinical Pharmacology|January 13, 2000
Decreased EEG sensitivity to alprazolam in subjects with a parental history of alcoholismO Sarid-Segal, C M Knapp, A M Ciraulo, et al.Journal of Psychopharmacology (Oxford, England)|October 8, 1999
In situ hybridization histochemistry as a method to assess GABA(A) receptor subunit mRNA expression following chronic alprazolam administrationJ M Fahey, G A Pritchard, J M Grassi, et al.Journal of Clinical Pharmacology|August 1, 1977
Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary resultsD J Greenblatt, W H Comer, H W Elliott, et al.British Journal of Anaesthesia|October 1, 1983
In vitro quantitation of benzodiazepine lipophilicity: relation to in vivo distributionD J Greenblatt, R M Arendt, D R Abernethy, et al.The Journal of Pharmacy and Pharmacology|May 26, 1998
Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in manK Venkatakrishnan, L L von Moltke, S X Duan, et al.The American Journal of Psychiatry|May 1, 1986
Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?G W Arana, D C Goff, H Friedman, et al.Biological Psychiatry|April 4, 2000
In vitro metabolism of trazodone by CYP3A: inhibition by ketoconazole and human immunodeficiency viral protease inhibitorsA Zalma, L L von Moltke, B W Granda, et al.Pageof 30